Hcy accelerates the biological dysfunction of ANA-1 macrophages and vascular injure via Rap1A/MAPK signal

Author:

Huang Xiaobo1,Yang Yali2,Wang Lexin2,Liu Huijuan3,Yang Ziyao4,Li Xinyi2,Luo Huanyu5,Li Zhen2,Wang Yangjia2,Xu Xi2,Chi Hao5,Yang Guanhu6,Yang Xiaoling2

Affiliation:

1. Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Ningxia Medical University (The First People's Hospital of Yinchuan), Yinchuan, 750001, China

2. NHC Key Laboratory of Metabolic Cardiovascular Diseases Research, Ningxia Medical University

3. General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750000, China

4. School of Second Clinical Medicine, Ningxia Medical University, Yinchuan 750004, China

5. Clinical Medical College,Southwest Medical University, Luzhou 646000, China

6. Department of Specialty Medicine, Ohio University, Athens 45701, OH, United States

Abstract

Abstract

Hyperhomocysteinemia (HHcy) is a kind of risk factor for various vascular diseases. The dysfunction of macrophages plays a crucial role in the development of HHcy-aggravated vascular injury. However, macrophages injure is still unclear. In this study, we propose the hypothesis that the Rap1A/ERK1/2 signal pathway is responsible for mediating the dysfunction of macrophages in HHcy-induced vascular diseases. We found that Cell proliferation, migration and invasion ability were increased after Hcy treatment. In addition, the mRNA levels of CD80 and CD86, and protein expression of Rap1A, iNOS were also increased in Hcy group. Interference of Rap1A reversed Hcy-induced cell proliferation, migration and invasion, and also reduced macrophage inflammatory response and M1 polarization. Phosphorylation of ERK1/2 was inhibited after Rap1A knockdown. Suppression of ERK1/2 alleviated Hcy-induced macrophage dysfunction. Together, Rap1A mediates Hcy-induced macrophage dysfunction via ERK1/2 signaling, which highlights a new mechanism in the pathogenesis and development of HHcy-aggravated vascular diseases.

Publisher

Springer Science and Business Media LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3